EXGILIA Trademark

Trademark Overview

On Wednesday, February 16, 2022, a trademark application was filed for EXGILIA with the United States Patent and Trademark Office. The USPTO has given the EXGILIA trademark a serial number of 79337829. The federal status of this trademark filing is REGISTERED as of Tuesday, June 20, 2023. This trademark is owned by IPSEN PHARMA S.A.S. The EXGILIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the field of oncology, namely, for the treatment of oncological diseases and disorders
exgilia

General Information

Serial Number79337829
Word MarkEXGILIA
Filing DateWednesday, February 16, 2022
Status700 - REGISTERED
Status DateTuesday, June 20, 2023
Registration Number7082650
Registration DateTuesday, June 20, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations in the field of oncology, namely, for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIPSEN PHARMA S.A.S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameIPSEN PHARMA S.A.S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameIPSEN PHARMA S.A.S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 25, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 25, 2023FINAL DISPOSITION PROCESSED
Wednesday, September 20, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 20, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 20, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Monday, March 27, 2023INTERNATIONAL REGISTRATION RENEWED
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 27, 2023REFUSAL PROCESSED BY IB
Monday, February 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 23, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 27, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 27, 2023REFUSAL PROCESSED BY MPU
Saturday, December 10, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 9, 2022NON-FINAL ACTION WRITTEN
Thursday, December 1, 2022ASSIGNED TO EXAMINER
Tuesday, April 12, 2022APPLICATION FILING RECEIPT MAILED
Friday, April 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 7, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

exgilia oncological diseases disorders treatment namely preparations field oncology pharmaceutical